Most health care payers are worried about gene therapy treatments that will cost hundreds of thousands of dollars, which is why most are looking into alternative payment plans to cover the new technology.
Category: NASDAQ:RGNX
RegenXBio Gene Therapy Shows Early Promise Eye Disease; Cholesterol Treatment Results Mixed
A gene therapy being developed by RegenX Bio of Rockville, MD, showed early promise against wet macular degeneration, a leading cause of blindness.
